• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Giornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia

    Giornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia

    Journal

    年发文量

    研究主题

    论文(2603)

    排序
    1Use of NxStage VersiHD for Frequent Home Hemodialysis in a Hospital Setting: A New Opportunity for Complex Patients.
    Marco Heidempergher, Michela Tedesco, Maurizio A Gallieni

    Background. The spread of home hemodialysis is increasing in Italy and across Europe, as noted in the document ("La diffusione dell'emodialisi domiciliare sta aumentando in Italia ed in Europa"). Its main feature enabling hospital use is its portability and independence from centralized water treatment systems, thanks to the use of sterile pre-mixed dialysate bags. This allows treatments to be delivered in environments not traditionally equipped for dialysis, such as isolation rooms on inpatient wards, emergency departments, or temporary units prior to definitive intrahospital transfer. Materials and Methods. Dialysis therapy used: The NxStage VersiHD system was employed to perform hemodialysis in three clinical scenarios: 1. Non-transportable patient with anasarca and acute kidney injury. The patient, hospitalized in the pulmonology ward and receiving oxygen therapy via tracheostomy, developed acute kidney injury with anuria requiring renal replacement therapy. The NxStage VersiHD device, already available in the dialysis unit, was transported to the patient's room. Two treatments were performed using 25 L of dialysate: the first lasting 3 hours and the second 4 hours. The system was used emergently for ultrafiltration and solute clearance until spontaneous diuresis resumed, despite a logistically challenging setting. 2. Chronic hemodialysis patient presenting to the emergency department with severe dyspnea due to fluid overload and SARS-CoV-2 infection. Because timely isolation in the dialysis unit was not feasible, urgent hemodialysis was performed using the NxStage VersiHD in a day-hospital room of our department, achieving reduction of pulmonary edema. 3. A 61-year-old woman with cirrhosis presented with splenic hemorrhage and acute renal failure. Admitted to intensive care, she underwent CVVHDF for 72 hours. She was transferred to the nephrology ward, which was not transportable due to the risk of hemorrhage. The NxStage VersiHD and the necessary equipment for dialysis scheduled for the following day were transported to the ward. Conclusions. The report aims to highlight the feasibility of using a home-designed dialysis technology safely within specific intrahospital contexts, offering an alternative strategy for dialysis support when infrastructural limitations or patient immobility prevent standard approaches. Staff training on NxStage operation, emergency procedures, and complication management is essential to minimize human error. The main challenges in training hospital nursing teams for occasional NxStage use include limited operational familiarity, management of device-specific complications, and integration of safety protocols. Operational unfamiliarity arises because, although NxStage is designed to simplify setup through preassembled cartridges and sterile dialysate bags, it differs technically from conventional dialysis systems. Lack of routine use is the primary reason for failure of NxStage implementation projects in hospital settings. To address this issue, our center adopted continuous use of NxStage in the dialysis unit for selected patients, ensuring regular machine operation. To avoid inadequate clearance with a thrice weekly schedule, 4 hour sessions were performed in patients with a distribution volume compatible with achieving a weekly Kt/V of 2.2, in accordance with international guidelines.

    2026
    引用
    AI阅读
    加入学术空间
    2[Hypertriglyceridemia, Chronic Kidney Disease, and Proteinuria: A Rare Case of Apolipoprotein C-II Amyloidosis].
    Fabio Mazza, Filomena Rubino, Angela Cicciarelli, Francesca Apponi, Bruna Cerbelli, Andrea Ascione,Mario Nuvolone, Ernesto Ansemo Cioffi

    We report the case of a 64-year-old man referred for evaluation of progressive renal dysfunction associated with hypertriglyceridemia and non-nephrotic proteinuria. There was no evidence of plasma cell dyscrasia, chronic inflammatory disease, or other secondary causes of amyloidosis. Renal biopsy revealed amyloid deposits with predominant glomerular involvement. Congo red staining confirmed the presence of amyloid, showing characteristic apple-green birefringence under polarized light. Immunohistochemical studies were non-diagnostic. Therefore, laser microdissection followed by mass spectrometry-based proteomic analysis was performed and identified apolipoprotein C-II (ApoC-II) as the main component of the amyloid deposits. Genetic analysis subsequently demonstrated a heterozygous c.122A>C (p.Lys41Thr) variant in the APOC2 gene, confirming the diagnosis of hereditary apolipoprotein C-II-related amyloidosis (AApoC-II), a very rare form of hereditary amyloidosis with predominant renal tropism.

    2026
    引用
    AI阅读
    加入学术空间
    3Beyond Compensation: Hyperinsulinemia As an Early Driver of Cardiovascular-Kidney-Metabolic Syndrome.
    Rodrigo Daza Arnedo, Rodolfo Fernando Rivera,Maria Teresa Sciarrone-Alibrandi, Carlos Manuel Restrepo G, María Ximena Cardona, Joaquín Armenta, Gabriela Fernández, Javier Jiménez Quintero, Francisco Javier Escalada San Martin,Jorge Rico Fontalvo

    Background. Cardiovascular-kidney-metabolic (CKM) syndrome encompasses obesity, type 2 diabetes, cardiovascular disease, and chronic kidney disease. Insulin resistance has traditionally been considered the primary driver, with hyperinsulinemia viewed as a compensatory response. However, emerging evidence suggests that hyperinsulinemia may precede insulin resistance in specific phenotypes and contribute to early disease mechanisms. Methods. We conducted a narrative review of the role of hyperinsulinemia in CKM syndrome. Literature searches were performed in PubMed/MEDLINE, Embase, and Scopus through December 2025. We prioritised prospective cohort studies, meta-analyses, Mendelian randomisation studies, and randomised controlled trials, and synthesised evidence across cardiovascular, renal, and metabolic domains. Results. Sustained hyperinsulinemia is associated with myocardial hypertrophy and fibrosis through selective preservation of mitogenic signalling, contributing to heart failure phenotypes. In the kidney, it enhances sodium and glucose reabsorption, increases intraglomerular pressure, and promotes podocyte dysfunction, potentially accelerating CKD progression. Epidemiological evidence consistently shows associations between elevated fasting insulin levels and cardiovascular events, renal outcomes, and mortality across diverse populations, with meta-analytic estimates reporting a pooled relative risk of 1.46 (95% CI 1.16-1.84) for incident cardiovascular events. However, available data are largely observational and heterogeneous in exposure definitions and adjustment models. Conclusions. Hyperinsulinemia represents a clinically relevant and potentially modifiable component of CKM syndrome, with effects extending beyond glucose homeostasis. While causality is biologically plausible and supported by genetic and epidemiological evidence, it remains to be established through interventional studies. Recognition of hyperinsulinemia may support earlier risk stratification and mechanism-based interventions, although prospective validation is required before routine clinical implementation.

    2026
    引用
    AI阅读
    加入学术空间
    4[Treatment of Hypercholesterolemia in Chronic Kidney Disease: Rationale and Therapeutic Approaches from the Non-Dialysis Stage to Kidney Transplantation].
    Roberto Minutolo,Maura Ravera,Mario Cozzolino,Luca Di Lullo,Ernesto Paoletti,Luca De Nicola

    Throughout the natural history of chronic kidney disease (CKD), most patients experience fatal or non-fatal cardiovascular events. In this review, we address the role of low-density lipoprotein cholesterol (LDL-C) in the excess cardiovascular risk associated with CKD and examine the impact of both traditional and novel LDL-C-lowering therapies across the entire spectrum of CKD. Current guidelines for the prevention of atherosclerotic cardiovascular disease (ASCVD), developed by European and US cardiology societies, recommend assessment of overall cardiovascular risk to tailor the intensity of preventive strategies to the individual patient's risk profile: the higher the cardiovascular risk, the more intensive the intervention should be. Novel therapies have demonstrated efficacy in achieving lower LDL-C targets, which are often unattainable with conventional treatment. The identification of vulnerable coronary plaques, rather than the mere presence of vascular lumen narrowing, represents a promising imaging target for guiding intensified preventive strategies in high-risk populations, including patients with CKD. In CKD, cardiovascular risk progressively increases as kidney function declines. Despite clear recommendations from both nephrology and non-nephrology guidelines, initiation, maintenance, and intensification of lipid-lowering treatment, as well as achievement of LDL-C targets, remain suboptimal in the CKD population. As novel lipid-lowering therapies provide additional therapeutic options for patients with CKD, there is now a compelling need to increase awareness of cardiovascular risk and integrate lipid management into the broader, longitudinal care of patients with CKD across all stages of the disease.

    2026
    引用
    AI阅读
    加入学术空间
    5[Ultrasound Reporting in Nephrology: Medico-Legal Considerations and Practical Issues].
    Vincenzo Barbera,Antonio Bellasi, Lorenzo D'Elia,Luca Di Lullo, Deborah Di Vico, Andrea Dello Strologo, Giovanni Otranto, Paola Peverini, Pasquale Saporito, Annalisa Villani, Aldo Franculli

    Ultrasound is nowadays widely used in nephrological practice as a first-line clinical tool. Despite this widespread adoption of the technique, the medico-legal aspects of ultrasound reporting have so far received limited attention, even though the report represents the formal completion of the medical act and the only document endowed with probative value. In the legal context, in fact, the ultrasound examination can be assessed exclusively through what is documented in the report, regardless of the technical quality of the examination itself. The present paper analyzes the main medico-legal aspects of ultrasound reporting, with particular reference to the activity of the nephrologist, focusing on the essential requirements of the report, the most common critical issues with medico-legal relevance, and the implications in terms of professional liability. The role of declaring the limitations of the examination and of structured reporting as possible tools for clinical risk management and professional protection will also be examined.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 2603 篇论文

    高被引作者

    作者引用发文
    F P Schena112139
    Luca Di Lullo110938
    Antonio Granata101060
    Biagio Di Iorio99846
    Cozzolino Mario97344
    Fiorini Fulvio95449
    Giuseppe Remuzzi8694
    Luca De Nicola81542
    Giuseppe Quintaliani80545
    Carmine Zoccali79831

    高产作者

    作者引用发文
    Antonio Granata101060
    Fiorini Fulvio95449
    Biagio Di Iorio99846
    Giuseppe Quintaliani80545
    Cozzolino Mario97344
    Luca De Nicola81542
    F P Schena112139
    Antonio Bellasi77438
    Domenico Santoro55138
    Luca Di Lullo110938

    相关期刊

    Nihon Jinzo Gakkai shi
    Kidney international. Supplement
    The journal of nephrology social work
    International journal of nephrology and kidney failure
    Advances in peritoneal dialysis. Conference on Peritoneal Dialysis
    Jornal Brasileiro De Nefrologia
    portuguese journal of nephrology and hypertension
    Journal of Integrative Nephrology and Andrology
    Kidney Diseases
    Women